Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events (Details Narrative)

v3.21.1
Subsequent Events (Details Narrative) - Subsequent Event [Member] - License Agreement [Member] - New Life Therapeutics PTE [Member]
May 02, 2021
USD ($)
Cash upfront payment $ 500,000
Deferred license fee 1,000,000
Revenue recognization of payment $ 19,000,000
Minimum [Member]  
Royalty ranger percentage 12.00%
Maximum [Member]  
Royalty ranger percentage 30.00%